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From the Departments of Chemical Pathology and IHaematology, St James's University Hospital, Leeds LS9 '7TF, UK Additional key phrases: phosphate depletion; hypocalcaemia Severe hypophosphataemia (serum phosphate concentration less than O' 32 mmollL) due to phosphate depletion can lead to a number of serious complications if left uncorrected including respiratory failure, cardiac failure and haemolytic anaemia.':" These effects are secondary to intracellular depletion of adenosine triphosphate (ATP). 4 The management of phosphate depletion has been controversial as intravenous phosphate in high doses can cause widespread metastatic calcification and severe hypocalcaemia. In addition, patients in renal failure are likely to develop hyperkalaemia. In view of these problems, it is recommended that low doses of intravenous phosphate are given and that serum calcium, potassium and phosphate concentrations are measured regularly during the course of management. 5 We report the results of ionized calcium assays during the treatment of three severely hypophosphataemic patients and TmP/GFR ratios prior to the commencement of therapy. The TmP/GFR ratio (a measure of the renal tubular reabsorption of phosphate) was used to help elucidate the source of phosphate loss.
CASE REPORTS
Case 1 A 57-year-old woman with an eating disorder which consisted of fasts lasting for several weeks followed by a carbohydrate binge was admitted to hospital in a state of collapse with profound muscular weakness. She was found to be both hyponatraemic (sodium 118 mmollL (reference range 135-145» and hypokalaemic (potassium 1'4mmollL (reference range 3'7-5'1», with normal biochemical tests of renal function but clinically dehydrated. Initial treatment was by Correspondence: Dr S Coyle rehydration. She received a mixture of saline and dextrose infusions with potassium supplementation. Her muscle weakness failed to resolve and if anything became worse despite adequate correction of the serum potassium concentration. In view of the patient's apparent malnutrition, a calcium profile was checked and the following results were found (reference ranges in parentheses): adjusted calcium 2· 28 mmollL (2' 20-2' 60); phosphate 0·08 mmollL (0'8-1'3) and alkaline phosphatase 143 U/L (70-300). In addition, faecal occult blood tests were positive, perhaps indicating early platelet dysfunction which is often seen in severe hypophosphataemia. The platelet count was 144x10 9/L (140-380x10 9 ) . In view of the extremely low phosphate concentration, TmPIGFR ratio was measured prior to initiation of therapy with the regime as recommended by Vannatta et al:" (9 mmol of monobasic potassium phosphate in half strength physiological saline by continuous intravenous infusion given 12 hourly) [TmP/GFR was derived from a nomogram"]. The TmP/GFR ratio was low at O' 17 mmollL (0' 80-1 . 35).
The intravenous infusion was discontinued 48 h later when the serum phosphate concentration had reached O' 55 mmollL and oral phosphate supplementation was commenced. During the period of treatment, ionized calcium levels fell as low as O' 88 mmollL (1,14-1' 28) (Nova I, Nova Biomedical, Waltham, MA 02154, USA) without symptoms. The patient made a full recovery becoming fully mobile again and was discharged home 3 weeks after admission with normal electrolyte, calcium and phosphate concentrations.
Case 2 A 46-year-old woman suffering from acute myeloid leukaemia was admitted to hospital to be prepared for an autologous bone marrow transplant. She had been transferred from another hospital after having total body irradiation. Her admission biochemical profile showed her to be hypokalaemic (potassium 2'6 mmol/L), hypophosphataemic (phosphate O·r:n mmol/L) and normocalcaemic (adjusted calcium 2· 24 mmol/L), all other measurements being normal. Treatment was initiated with the Vannatta regime after measurement of TmP/GFR ratio which was low at 0'17. The patient, who had previously complained of feeling weak, remarked on feeling much better after 24 h of treatment. Intravenous infusion of phosphate was discontinued after 36 h, when the serum phosphate concentration had reached O'38 mmol/L. The patient was then started on oral phosphate supplementation. Ionized calcium concentration fell to I . 07 mmollL during treatment without symptoms, but the patient unfortunately died in cardiac failure I week after admission.
Case 3
A 61-year-old man complaining of dysphagia and stridor at rest was found to have a laryngeal mass invading the pharynx. He underwent a radical pharyngo-laryngectomy which involved removing all four parathyroid glands. He was subsequently started on Io-hydroxycholecalciferol and his post-operative hypocalcaemia (ionized calcium O' 8 mmol/L) was managed with repeated injections of calcium gluconate. Unfortunately, his serum phosphate fell to O·30 rnmol/L, with an ionized calcium concentration at this stage of 0·81 mmollL and normal biochemical tests of renal function. TmP/GFR was 0'64. An intravenous infusion of phosphate was commenced in the contralateral arm to the one used for the calcium gluconate injections after an interval of 2 h. The patient's serum phosphate rose quickly to O' 66 mmollL after 7 h infusion enabling the infusion to be discontinued. Ionized calcium levels fell to O' 72 mmollL, again without the patient sustaining symptoms of hypocalcaemia.
DISCUSSION
All three patients exhibited varying degrees of severe hypophosphataemia. In Case I, hypophosphataemia had a well recognized association with starvation. Carbohydrate binges following periods of starvation would have further lowered the serum phosphate levels due to the carbohydrate-induced insulin surge driving phosphate into cells. In Case 2, the patient's hypophosphataemia was primarily attributed to a resurgence in growth of leukaemic cells coupled with renal phosphate loss secondary to chemotherapy. In Case 3, the patient had a total parathyroidectomy which would normally lead to hyperphosphataemia. However, the repeated administration of calcium gluconate in an attempt to relieve the hypocalcaemia is likely to have caused metastatic deposition of phosphate. Hypophosphataemia may have been further exacerbated by enteral feeding after a period of enforced fasting due to dysphagia.
Cases I and 2 appear to have been severely depleted of phosphate both intra-and extracellularly in view of the length of time taken for serum phosphate concentrations to respond to intravenous phosphate infusion. In Case 3, the more rapid response suggested a redistribution problem with extra-cellular concentrations depleted more than intra-cellular because of metastatic precipitation after calcium gluconate injections. Thus serum phosphate concentrations may be a poor reflection of total intra-cellular phosphate.
In the first two cases extra-cellular hypophosphataemia was exacerbated by the administration of dextrose/potassium infusions to correct hypokalaemia before serum phosphate concentrations were measured, causing phosphate to move into cells along with glucose and potassium.
The TmP/GFR ratio was low in all three patients indicating renal loss of phosphate prior to commencement of therapy. At very low serum phosphate concentration most cells, including renal tubular cells, become depleted of phosphate. Intra-cellular ATP concentrations have been shown to correlate closely with serum phosphate concentrations in the absence of phosphate redistributlon.t At low concentrations of intracellular ATP it seems likely that the renal tubular cells will become 'sick' and the tubular reabsorption of phosphate will be impaired. Additional support for this hypothesis comes from Case 3 where the TmP/GFR was only slightly lowered (0' 64) despite severe hypophosphataemia suggesting that intra-cellular phosphate and ATP levels were maintained. TmP/GFR is therefore not a useful indicator of the primary source of phosphate loss at very low serum phosphate concentrations not due to redistribution, as it will invariably be low. However, TmP/GFR remains useful in deciding the need for therapy since a low value indicates renal loss of phosphate irrespective of the primary cause of the hypophosphataemia. -Finally, despite low ionized calcium values (as low as O' 72 mmol/L) during the treatment of all three patients (Case 3 was already hypocalcaemic at the start of treatment but encountered a further fall), treatment was able to continue as the patients remained asymptomatic. The primary objective was to correct the severe hypophosphataemia and it is likely that the absence of symptoms of hypocalcaemia was because the rate of change in ionized calcium was low. Alkalosis due to hypokalaemia may have contributed to the low ionized calcium in Cases I and 2, but we have no pH data. However, the ionized calcium concentration continued to fall after potassium repletion during the administration of phosphate in both Cases 1 and 2. Vannatta et al. encountered only one patient in their series of 10 cases who developed hypocalcaemia during treatment, although total calcium rather than ionized calcium was measured. It is possible that during treatment a calcium phosphate complex forms that reacts with colorimetric methods for measuring calcium and that ionized calcium would prove better for assessing calcium status during therapy.
